Paradigm Biopharmaceuticals Limited (ASX:PAR) Directors Insider Transactions
The Directors and Chief Executives of Paradigm Biopharmaceuticals Limited (ASX:PAR) are required by law to report any insider transaction activities i.e. buying, selling, option exercising the Paradigm Biopharmaceuticals Limited's shares in the stock market. Below table shows the list of insider transactions as reported by Paradigm Biopharmaceuticals Limited to the ASX stock exchange.
An insider trade occurs when an individual (such as a CEO, CFO or COO) that has non-public information about a company buys or sells shares of that company's stock. Tracking a company's insider trades is a metric that can be used to identify the direction that the company's executives believes that the company is headed. For example, if a number of insiders purchase more shares of a company, they may believe that the company will have strong future earnings and that the share price will increase in the near future.
Paradigm Biopharmaceuticals Limited Directors/Insider Transactions Activity
List of Insider trades activity from Paradigm Biopharmaceuticals Limited (PAR).
| Date | Director | Director's Title | Shares | Value | Note |
|---|---|---|---|---|---|
| 21 Nov 2024 | Rennie (Paul) | Managing Director | 197,355 | - | - |
| 15 Oct 2024 | Rennie (Paul) | Managing Director | 95,300 | 13,494 | Purchase at price 0.14 per share. |
| 14 Oct 2024 | Fry (Matthew James) | Director (Non-Executive) | 200,000 | 28,740 | Purchase at price 0.14 per share. |
| 10 Oct 2024 | Fry (Matthew James) | Director (Non-Executive) | 150,000 | 20,550 | Purchase at price 0.14 per share. |
| 10 Oct 2024 | Rennie (Paul) | Managing Director | 150,000 | 20,670 | Purchase at price 0.14 per share. |
| 04 Mar 2024 | Fisher (Helen) | Retired | 11,225 | - | - |
| 04 Mar 2024 | Fry (Matthew James) | Director (Non-Executive) | 1,069,830 | - | - |